<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="3-part\PMC7077973\results\search\disease\results.xml">
  <result pre="without permission from the journal.olq-47-224.pdf There is considerable interest in" exact="syphilis" post="preexposure (44.1%) and postexposure (60.1%) prophylaxis among gay, bisexual,"/>
  <result pre="health clinics. Abstract Background We assessed the acceptability of doxycycline-based" exact="syphilis" post="pre-exposure and post-exposure prophylaxis (PrEP/PEP) as well as human"/>
  <result pre="and constructed multivariable logistic regression models for willingness to use" exact="syphilis" post="and HIV PrEP and PEP respectively. Results Among 424"/>
  <result pre="was 6.0 (3.0–13.0), and 18.2% had 1 or more prior" exact="syphilis" post="diagnosis. 60.1%/44.1% indicated willingness to use syphilis PEP/PrEP; 36.6%"/>
  <result pre="or more prior syphilis diagnosis. 60.1%/44.1% indicated willingness to use" exact="syphilis" post="PEP/PrEP; 36.6% were unwilling to use either. Among HIV-negative"/>
  <result pre="participants were familiar with antibiotic resistance (89.0%) and agreed that" exact="syphilis" post="rates are rising in Canada (68.2%), but only 55.4%"/>
  <result pre="with the latter statement was associated with willingness to use" exact="syphilis" post="PrEP (adjusted odds ratio [aOR], 1.6; 95% confidence interval"/>
  <result pre="1.9; 95% CI, 1.0–3.4). Odds of being willing to use" exact="syphilis" post="PEP were higher in Toronto versus Vancouver (aOR, 2.0;"/>
  <result pre="1.4; 95% CI, 1.2,1.7). Conclusions There is considerable interest in" exact="syphilis" post="PrEP/PEP in gbMSM attending Toronto/Vancouver STI clinics. There are"/>
  <result pre="human immunodeficiency virus (HIV) acquisition risk 3- to 4-fold,6 and" exact="syphilis" post="may more commonly cause neurological complications in those already"/>
  <result pre="PEP.8–10 In 2015, a pilot study of daily doxycycline as" exact="syphilis" post="PrEP in HIV-positive gbMSM in Los Angeles demonstrated a"/>
  <result pre="first episode of chlamydia (HR, 0.30; 95% CI, 0.13–0.70) and" exact="syphilis" post="(HR, 0.27; 95% CI, 0.07–0.98).10 However, these strategies are"/>
  <result pre="willing to use 2 hypothetical forms of STI prevention: doxycycline-based" exact="syphilis" post="PrEP and PEP. Secondary objectives were: (i) to determine"/>
  <result pre="to questionnaire items asking about their willingness to use hypothetical" exact="syphilis" post="PrEP or syphilis PEP. The PrEP question was phrased"/>
  <result pre="asking about their willingness to use hypothetical syphilis PrEP or" exact="syphilis" post="PEP. The PrEP question was phrased as follows: &quot;Syphilis"/>
  <result pre="built separate multivariable logistic regression models for willingness to use" exact="syphilis" post="PrEP, syphilis PEP, HIV PrEP, and HIV PEP, using"/>
  <result pre="multivariable logistic regression models for willingness to use syphilis PrEP," exact="syphilis" post="PEP, HIV PrEP, and HIV PEP, using the total"/>
  <result pre="in the final PrEP and PEP models for each of" exact="syphilis" post="or HIV. Finally, we used descriptive statistics to characterize"/>
  <result pre="needed to ascertain the proportion of gbMSM willing to use" exact="syphilis" post="PrEP and/or PEP with reasonable precision, defined here as"/>
  <result pre="ever having been diagnosed with 1 or more of chlamydia," exact="gonorrhea" post="or syphilis, and 28 (6.6%) participants reported living with"/>
  <result pre="Although the majority of participants (60.1%) indicated willingness to use" exact="syphilis" post="PEP in the future, only 44.1% of participants responded"/>
  <result pre="in the future, only 44.1% of participants responded similarly for" exact="syphilis" post="PrEP (Fig. 1). Moreover, 40.8% of participants were willing"/>
  <result pre="1). Moreover, 40.8% of participants were willing to use both" exact="syphilis" post="prevention techniques, and 36.6% were unwilling to use either"/>
  <result pre="pass on the virus through sex.�? Most (68.2%) agreed that" exact="syphilis" post="is on the rise in Canada and 55.4% of"/>
  <result pre="Use STI Prevention Strategies Significant predictors for willingness to use" exact="syphilis" post="and HIV PrEP/PEP varied (Tables 2 and 3). In"/>
  <result pre="(Tables 2 and 3). In multivariable analyses, willingness to use" exact="syphilis" post="PrEP was significantly associated with being &quot;very concerned�? about"/>
  <result pre="CI, 1.0–2.5). Interestingly, variables that are more traditionally related to" exact="syphilis" post="risk, such as the total number of sex partners"/>
  <result pre="total number of sex partners and a prior diagnosis of" exact="syphilis" post="were not significantly associated with willingness to use syphilis"/>
  <result pre="of syphilis were not significantly associated with willingness to use" exact="syphilis" post="PrEP in this analysis. In fact, the total number"/>
  <result pre="predictor of interest, was not associated with interest in either" exact="syphilis" post="PrEP or PEP. Willingness to use syphilis PEP was"/>
  <result pre="interest in either syphilis PrEP or PEP. Willingness to use" exact="syphilis" post="PEP was only significantly associated with a higher number"/>
  <result pre="participants (60.1%) were willing to use doxycycline-based PEP to prevent" exact="syphilis" post="acquisition after a high-risk exposure, demonstrating fairly high acceptability"/>
  <result pre="2095 gay male survey participants in Australia willing to use" exact="syphilis" post="PrEP,19 compared with 84% of 1301 gbMSM survey respondents"/>
  <result pre="gbMSM survey respondents in the United States willing to try" exact="syphilis" post="PEP in the future.20 In our study, willingness appeared"/>
  <result pre="chance of acquiring STIs, such as feeling at risk for" exact="syphilis" post="and being concerned about acquiring it, and with traditional"/>
  <result pre="in the past 6 months nor a prior history of" exact="syphilis" post="was associated with willingness to use syphilis PrEP or"/>
  <result pre="prior history of syphilis was associated with willingness to use" exact="syphilis" post="PrEP or PEP in multivariable models. Given that many"/>
  <result pre="was the variable most strongly associated with willingness to use" exact="syphilis" post="PrEP in our multivariable model. This finding is encouraging,"/>
  <result pre="our team are currently conducting an exploratory trial of combined" exact="syphilis" post="and HIV PrEP using both daily doxycycline and tenofovir"/>
  <result pre="use HIV PrEP and PEP were considerably higher than for" exact="syphilis" post="PrEP and PEP, at 74.0% and 75.2% respectively. These"/>
  <result pre="suggest an increasingly favorable environment for the potential use of" exact="syphilis" post="PrEP and PEP within the target population. Indeed, being"/>
  <result pre="by HIV status. In addition, data on willingness to use" exact="syphilis" post="PrEP/PEP may not be an accurate indicator of future"/>
  <result pre="behavior. Further, because we did not specify the efficacy of" exact="syphilis" post="PrEP/PEP in the wording of our questions, results may"/>
  <result pre="these interventions would confer complete protection. Also, our descriptions of" exact="syphilis" post="PrEP/PEP assumed quarterly bloodwork/clinic visits, mimicking the schedules being"/>
  <result pre="this is the first study to assess the acceptability of" exact="syphilis" post="PrEP and PEP in Canada. Overall, we observed that"/>
  <result pre="and efficacious. Although preliminary studies have indicated the effectiveness of" exact="syphilis" post="chemoprophylaxis, larger clinical trials are underway to substantiate these"/>
  <result pre="controlled trial. JAMA2004; 291:2555–2562.15173146 9BolanRKBeymerMRWeissREet al.Doxycycline prophylaxis to reduce incident" exact="syphilis" post="among HIV-infected men who have sex with men who"/>
  <result pre="19WilsonDPPrestageGPGrayRTet al.Chemoprophylaxis is likely to be acceptable and could mitigate" exact="syphilis" post="epidemics among populations of gay men. Sex Transm Dis2011;"/>
 </snippets>
</snippetsTree>
